LEAT

SEC source: 0001062993-22-004496 · form4.xml · nonDerivative · entry 2

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,022,514

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021, for the sale of up to 200,000 shares of common stock, through November 16, 2022. Sale prices on January 13, 18-21, and 24-27 reflect average sale prices for multiple sales each day ranging from $23.72 - $30.43 per share.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021, for the sale of up to 200,000 shares of common stock, through November 16, 2022. Sale prices on January 13, 18-21, and 24-27 reflect average sale prices for multiple sales each day ranging from $23.72 - $30.43 per share.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021, for the sale of up to 200,000 shares of common stock, through November 16, 2022. Sale prices on January 13, 18-21, and 24-27 reflect average sale prices for multiple sales each day ranging from $23.72 - $30.43 per share.

F2 · balance_after: Represents aggregate sales of 30,000 shares of the Issuer's common stock effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021, for the sale of up to 200,000 shares of common stock, through November 16, 2022. Sale prices on January 13, 18-21, and 24-27 reflect average sale prices for multiple sales each day ranging from $23.72 - $30.43 per share. The Reporting Person previously reported the sale of 14,000 shares under the plan, which leaves a remaining balance of 156,000 shares that may be sold under the plan.

F2 · ownership.direct: Represents aggregate sales of 30,000 shares of the Issuer's common stock effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021, for the sale of up to 200,000 shares of common stock, through November 16, 2022. Sale prices on January 13, 18-21, and 24-27 reflect average sale prices for multiple sales each day ranging from $23.72 - $30.43 per share. The Reporting Person previously reported the sale of 14,000 shares under the plan, which leaves a remaining balance of 156,000 shares that may be sold under the plan.

F2 · ownership.nature: Represents aggregate sales of 30,000 shares of the Issuer's common stock effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021, for the sale of up to 200,000 shares of common stock, through November 16, 2022. Sale prices on January 13, 18-21, and 24-27 reflect average sale prices for multiple sales each day ranging from $23.72 - $30.43 per share. The Reporting Person previously reported the sale of 14,000 shares under the plan, which leaves a remaining balance of 156,000 shares that may be sold under the plan.

SEC source: 0001062993-22-004496 · form4.xml · nonDerivative · entry 1

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,023,014

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021, for the sale of up to 200,000 shares of common stock, through November 16, 2022. Sale prices on January 13, 18-21, and 24-27 reflect average sale prices for multiple sales each day ranging from $23.72 - $30.43 per share.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021, for the sale of up to 200,000 shares of common stock, through November 16, 2022. Sale prices on January 13, 18-21, and 24-27 reflect average sale prices for multiple sales each day ranging from $23.72 - $30.43 per share.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021, for the sale of up to 200,000 shares of common stock, through November 16, 2022. Sale prices on January 13, 18-21, and 24-27 reflect average sale prices for multiple sales each day ranging from $23.72 - $30.43 per share.

F2 · balance_after: Represents aggregate sales of 30,000 shares of the Issuer's common stock effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021, for the sale of up to 200,000 shares of common stock, through November 16, 2022. Sale prices on January 13, 18-21, and 24-27 reflect average sale prices for multiple sales each day ranging from $23.72 - $30.43 per share. The Reporting Person previously reported the sale of 14,000 shares under the plan, which leaves a remaining balance of 156,000 shares that may be sold under the plan.

F2 · ownership.direct: Represents aggregate sales of 30,000 shares of the Issuer's common stock effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021, for the sale of up to 200,000 shares of common stock, through November 16, 2022. Sale prices on January 13, 18-21, and 24-27 reflect average sale prices for multiple sales each day ranging from $23.72 - $30.43 per share. The Reporting Person previously reported the sale of 14,000 shares under the plan, which leaves a remaining balance of 156,000 shares that may be sold under the plan.

F2 · ownership.nature: Represents aggregate sales of 30,000 shares of the Issuer's common stock effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021, for the sale of up to 200,000 shares of common stock, through November 16, 2022. Sale prices on January 13, 18-21, and 24-27 reflect average sale prices for multiple sales each day ranging from $23.72 - $30.43 per share. The Reporting Person previously reported the sale of 14,000 shares under the plan, which leaves a remaining balance of 156,000 shares that may be sold under the plan.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 28

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,024,614

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 27

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,025,814

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 26

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,026,114

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 25

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,026,414

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 24

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,027,514

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 23

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,028,214

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 22

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,029,714

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 21

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,030,114

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 20

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,030,314

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 19

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,030,814

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 18

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,031,314

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 17

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,031,614

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 16

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,032,214

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 15

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,032,714

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-000949 · form4.xml · nonDerivative · entry 2

Guzy Jeffrey J · CIK 0001415532 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,917

F3 · kind: On December 22, 2021, the Issuer's Board approved the award of 1,000 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan. Sixty percent, or 600 shares, of the restricted stock vested on December 31, 2021, and the remaining forty percent, or 400 shares, will vest on four equal parts on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022, respectively; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F3 · shares: On December 22, 2021, the Issuer's Board approved the award of 1,000 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan. Sixty percent, or 600 shares, of the restricted stock vested on December 31, 2021, and the remaining forty percent, or 400 shares, will vest on four equal parts on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022, respectively; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F1 · balance_after: The Reporting Person was the holder of 43,917 shares of the Issuer's common stock after giving effect to a 1-for-25 reverse split of the Issue's common stock effected on September 20, 2012.

F3 · balance_after: On December 22, 2021, the Issuer's Board approved the award of 1,000 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan. Sixty percent, or 600 shares, of the restricted stock vested on December 31, 2021, and the remaining forty percent, or 400 shares, will vest on four equal parts on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022, respectively; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

SEC source: 0001062993-22-001045 · form4.xml · nonDerivative · entry 3

Macdonald Sean · CIK 0001553633 · Director · CEO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,539

F3 · kind: On December 22, 2021, the Issue's Board approved the award of 12,500 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan. Sixty percent, or 7,500 shares, of the restricted stock vested on December 31, 2021, and the remaining forty percent, or 5,000 shares, will vest on four equal parts on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022, respectively; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F3 · shares: On December 22, 2021, the Issue's Board approved the award of 12,500 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan. Sixty percent, or 7,500 shares, of the restricted stock vested on December 31, 2021, and the remaining forty percent, or 5,000 shares, will vest on four equal parts on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022, respectively; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F3 · balance_after: On December 22, 2021, the Issue's Board approved the award of 12,500 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan. Sixty percent, or 7,500 shares, of the restricted stock vested on December 31, 2021, and the remaining forty percent, or 5,000 shares, will vest on four equal parts on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022, respectively; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F4 · balance_after: Total shares of common stock includes 60,901 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 14

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,033,214

F3 · kind: On December 22, 2021, the Issuer's Board approved the award of 8,500 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Amended and Restated Equity Incentive Plan. Sixty percent, or 5,100 shares, of the restricted stock vested on December 31, 2021, and the remaining forty percent, or 3,400 shares, will vest on four equal parts on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022, respectively; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F3 · shares: On December 22, 2021, the Issuer's Board approved the award of 8,500 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Amended and Restated Equity Incentive Plan. Sixty percent, or 5,100 shares, of the restricted stock vested on December 31, 2021, and the remaining forty percent, or 3,400 shares, will vest on four equal parts on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022, respectively; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 13

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,024,714

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 12

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,025,064

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-000949 · form4.xml · nonDerivative · entry 1

Guzy Jeffrey J · CIK 0001415532 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,917

F2 · kind: On November 22, 2016, the Issuer's Board of Directors approved the grant to the Reporting Person, of a 10-year option to purchase 10,000 shares of the Issuer's common stock at an exercise price of $2.60 a share under the Issuer's 2011 Amended and Restated Equity Incentive Plan, all of which vested by March 29, 2019. On December 20, 2021, the Reporting Person exercised his options to purchase 10,000 shares of the Issuer's Common Stock for an aggregate purchase price of $26,000.

F2 · shares: On November 22, 2016, the Issuer's Board of Directors approved the grant to the Reporting Person, of a 10-year option to purchase 10,000 shares of the Issuer's common stock at an exercise price of $2.60 a share under the Issuer's 2011 Amended and Restated Equity Incentive Plan, all of which vested by March 29, 2019. On December 20, 2021, the Reporting Person exercised his options to purchase 10,000 shares of the Issuer's Common Stock for an aggregate purchase price of $26,000.

F1 · balance_after: The Reporting Person was the holder of 43,917 shares of the Issuer's common stock after giving effect to a 1-for-25 reverse split of the Issue's common stock effected on September 20, 2012.

F2 · balance_after: On November 22, 2016, the Issuer's Board of Directors approved the grant to the Reporting Person, of a 10-year option to purchase 10,000 shares of the Issuer's common stock at an exercise price of $2.60 a share under the Issuer's 2011 Amended and Restated Equity Incentive Plan, all of which vested by March 29, 2019. On December 20, 2021, the Reporting Person exercised his options to purchase 10,000 shares of the Issuer's Common Stock for an aggregate purchase price of $26,000.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 11

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,025,564

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 10

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,026,064

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 9

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,026,074

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 8

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,026,564

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 7

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,027,064

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 6

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,027,564

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 5

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,027,864

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 4

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,028,614

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 3

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,028,964

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 2

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,029,364

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001074 · form4.xml · nonDerivative · entry 1

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,029,614

F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · shares: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F1 · balance_after: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family prior to the reporting date.

SEC source: 0001062993-22-001045 · form4.xml · nonDerivative · entry 2

Macdonald Sean · CIK 0001553633 · Director · CEO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,039

F2 · kind: On March 29, 2016, the Issuer's Board of Directors approved a grant to the Reporting Person, of a ten-year option to purchase 78,000 shares of the Issuer's common stock at $2.60 per share under the Issuer's 2011 Plan, which vested in full on December 31, 2019. On November 16, 2021, the Reporting Person exercised his option to purchase all 78,000 shares at an aggregate exercise price of $202,800. The purchase price was paid through a cashless transaction whereby the Issuer withheld 6,146 of the shares at the fair market value of $33 per share, in lieu of cash payment and the Reporting person received the remaining 71,854 shares.

F2 · shares: On March 29, 2016, the Issuer's Board of Directors approved a grant to the Reporting Person, of a ten-year option to purchase 78,000 shares of the Issuer's common stock at $2.60 per share under the Issuer's 2011 Plan, which vested in full on December 31, 2019. On November 16, 2021, the Reporting Person exercised his option to purchase all 78,000 shares at an aggregate exercise price of $202,800. The purchase price was paid through a cashless transaction whereby the Issuer withheld 6,146 of the shares at the fair market value of $33 per share, in lieu of cash payment and the Reporting person received the remaining 71,854 shares.

F2 · balance_after: On March 29, 2016, the Issuer's Board of Directors approved a grant to the Reporting Person, of a ten-year option to purchase 78,000 shares of the Issuer's common stock at $2.60 per share under the Issuer's 2011 Plan, which vested in full on December 31, 2019. On November 16, 2021, the Reporting Person exercised his option to purchase all 78,000 shares at an aggregate exercise price of $202,800. The purchase price was paid through a cashless transaction whereby the Issuer withheld 6,146 of the shares at the fair market value of $33 per share, in lieu of cash payment and the Reporting person received the remaining 71,854 shares.

F4 · balance_after: Total shares of common stock includes 60,901 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date.

SEC source: 0001062993-22-001045 · form4.xml · nonDerivative · entry 1

Macdonald Sean · CIK 0001553633 · Director · CEO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,755

F1 · kind: On August 24, 2017, the Issuer's Board of Directors approved a grant to the Reporting Person, of a ten-year option to purchase 78,000 shares of the Issuer's common stock at $1.60 per share under the 2011 Amended and Restated Equity Incentive Plan ("2011 Plan"), which vested in full on March 29, 2019. On November 16, 2021, the Reporting Person exercised his option to purchase 56,000 of these shares at an aggregate exercise price of $89,600. The purchase price was paid through a cashless transaction whereby the Issuer withheld 2,716 of the shares at the fair market value of $33 per share, in lieu of cash payment and the Reporting person received the remaining 53,284 shares.

F1 · shares: On August 24, 2017, the Issuer's Board of Directors approved a grant to the Reporting Person, of a ten-year option to purchase 78,000 shares of the Issuer's common stock at $1.60 per share under the 2011 Amended and Restated Equity Incentive Plan ("2011 Plan"), which vested in full on March 29, 2019. On November 16, 2021, the Reporting Person exercised his option to purchase 56,000 of these shares at an aggregate exercise price of $89,600. The purchase price was paid through a cashless transaction whereby the Issuer withheld 2,716 of the shares at the fair market value of $33 per share, in lieu of cash payment and the Reporting person received the remaining 53,284 shares.

F1 · balance_after: On August 24, 2017, the Issuer's Board of Directors approved a grant to the Reporting Person, of a ten-year option to purchase 78,000 shares of the Issuer's common stock at $1.60 per share under the 2011 Amended and Restated Equity Incentive Plan ("2011 Plan"), which vested in full on March 29, 2019. On November 16, 2021, the Reporting Person exercised his option to purchase 56,000 of these shares at an aggregate exercise price of $89,600. The purchase price was paid through a cashless transaction whereby the Issuer withheld 2,716 of the shares at the fair market value of $33 per share, in lieu of cash payment and the Reporting person received the remaining 53,284 shares.

F4 · balance_after: Total shares of common stock includes 60,901 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date.

SEC source: 0001062993-21-004185 · form4.xml · nonDerivative · entry 1

Guzy Jeffrey J · CIK 0001415532 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,917

F1 · kind: On December 29, 2020, the Issuer's Board approved the award of 2,250 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Amended and Restated Equity Incentive Plan. Sixty percent, or 1,350 shares, of the restricted stock vested immediately, on the date of the award, and the remaining forty percent, or 900 shares, will vest on two equal parts on December 29, 2021 and 2022, respectively, so long as the Reporting Person is fully employed by the Issuer on such vesting date; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F1 · shares: On December 29, 2020, the Issuer's Board approved the award of 2,250 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Amended and Restated Equity Incentive Plan. Sixty percent, or 1,350 shares, of the restricted stock vested immediately, on the date of the award, and the remaining forty percent, or 900 shares, will vest on two equal parts on December 29, 2021 and 2022, respectively, so long as the Reporting Person is fully employed by the Issuer on such vesting date; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F1 · price: On December 29, 2020, the Issuer's Board approved the award of 2,250 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Amended and Restated Equity Incentive Plan. Sixty percent, or 1,350 shares, of the restricted stock vested immediately, on the date of the award, and the remaining forty percent, or 900 shares, will vest on two equal parts on December 29, 2021 and 2022, respectively, so long as the Reporting Person is fully employed by the Issuer on such vesting date; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F1 · balance_after: On December 29, 2020, the Issuer's Board approved the award of 2,250 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Amended and Restated Equity Incentive Plan. Sixty percent, or 1,350 shares, of the restricted stock vested immediately, on the date of the award, and the remaining forty percent, or 900 shares, will vest on two equal parts on December 29, 2021 and 2022, respectively, so long as the Reporting Person is fully employed by the Issuer on such vesting date; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F2 · balance_after: Total common stock includes 41,667 shares of the Issuer's common stock directly held by the Reporting Person as at the transaction date.

SEC source: 0001062993-21-004183 · form4.xml · nonDerivative · entry 1

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,038,114

F1 · kind: On December 29, 2020, the Issuer's Board approved the award of 8,000 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan. Sixty percent, or 4,800 shares, of the restricted stock vested immediately, on the date of the award, and the remaining forty percent, or 3,200 shares, will vest on two equal parts on December 29, 2021 and 2022, respectively, so long as the Reporting Person is fully employed by the Issuer on such vesting date; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F1 · shares: On December 29, 2020, the Issuer's Board approved the award of 8,000 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan. Sixty percent, or 4,800 shares, of the restricted stock vested immediately, on the date of the award, and the remaining forty percent, or 3,200 shares, will vest on two equal parts on December 29, 2021 and 2022, respectively, so long as the Reporting Person is fully employed by the Issuer on such vesting date; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F1 · balance_after: On December 29, 2020, the Issuer's Board approved the award of 8,000 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan. Sixty percent, or 4,800 shares, of the restricted stock vested immediately, on the date of the award, and the remaining forty percent, or 3,200 shares, will vest on two equal parts on December 29, 2021 and 2022, respectively, so long as the Reporting Person is fully employed by the Issuer on such vesting date; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F2 · balance_after: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person as at the transaction date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family as at the transaction date.

F2 · ownership.direct: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person as at the transaction date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family as at the transaction date.

F2 · ownership.nature: Total common stock includes 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person as at the transaction date, and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family as at the transaction date.

SEC source: 0001062993-21-004179 · form4.xml · nonDerivative · entry 1

Macdonald Sean · CIK 0001553633 · Director · CEO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,901

F1 · kind: On December 29, 2020, the Issuer's Board approved the award of 11,800 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan. Sixty percent, or 7,080 shares, of the restricted stock vested immediately, on the date of the award, and the remaining 40%, or 4,720 shares, will vest on two equal parts on December 29, 2021 and 2022, respectively, so long as the Reporting Person is fully employed by the Issuer on such vesting date; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F1 · shares: On December 29, 2020, the Issuer's Board approved the award of 11,800 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan. Sixty percent, or 7,080 shares, of the restricted stock vested immediately, on the date of the award, and the remaining 40%, or 4,720 shares, will vest on two equal parts on December 29, 2021 and 2022, respectively, so long as the Reporting Person is fully employed by the Issuer on such vesting date; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F1 · balance_after: On December 29, 2020, the Issuer's Board approved the award of 11,800 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan. Sixty percent, or 7,080 shares, of the restricted stock vested immediately, on the date of the award, and the remaining 40%, or 4,720 shares, will vest on two equal parts on December 29, 2021 and 2022, respectively, so long as the Reporting Person is fully employed by the Issuer on such vesting date; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F2 · balance_after: Total common stock includes 49,101 shares of the Issuer's common stock held directly by the Reporting Person as at the transaction date.

SEC source: 0001062993-19-001995 · form4.xml · derivative · entry 1

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 252,000

Underlying: Common Stock, par value $0.001 per share · 52,000 shares

Expires 2029-02-24

F1 · kind: Total derivative securities include options to purchase 104,000 shares of the Issuer's common stock, held by the Reporting Person as at the transaction date, and 96,000 shares of the Issuer's preferred stock heldy by the Reporting Person, convertible to common stock at a rate of 1 share of common stock for each share of preferred stock. On February 25, 2019, the Reporting Person was granted options to purchase another 52,000 shares of the Issuer's common stock at $2.30 per share under the Issuer's 2011 Plan which will expire on February 24, 2029. Options to purchase 30% or 15,600 shares immediately vested, options to purchase another 40% or 20,800 shares will vest in two equal portions of 10,400 shares each on February 25, 2020 and 2021, respectively, and the remaining 30% or 15,600 shares will vest on February 25, 2022.

F1 · shares: Total derivative securities include options to purchase 104,000 shares of the Issuer's common stock, held by the Reporting Person as at the transaction date, and 96,000 shares of the Issuer's preferred stock heldy by the Reporting Person, convertible to common stock at a rate of 1 share of common stock for each share of preferred stock. On February 25, 2019, the Reporting Person was granted options to purchase another 52,000 shares of the Issuer's common stock at $2.30 per share under the Issuer's 2011 Plan which will expire on February 24, 2029. Options to purchase 30% or 15,600 shares immediately vested, options to purchase another 40% or 20,800 shares will vest in two equal portions of 10,400 shares each on February 25, 2020 and 2021, respectively, and the remaining 30% or 15,600 shares will vest on February 25, 2022.

F1 · derivative.exercise_date: Total derivative securities include options to purchase 104,000 shares of the Issuer's common stock, held by the Reporting Person as at the transaction date, and 96,000 shares of the Issuer's preferred stock heldy by the Reporting Person, convertible to common stock at a rate of 1 share of common stock for each share of preferred stock. On February 25, 2019, the Reporting Person was granted options to purchase another 52,000 shares of the Issuer's common stock at $2.30 per share under the Issuer's 2011 Plan which will expire on February 24, 2029. Options to purchase 30% or 15,600 shares immediately vested, options to purchase another 40% or 20,800 shares will vest in two equal portions of 10,400 shares each on February 25, 2020 and 2021, respectively, and the remaining 30% or 15,600 shares will vest on February 25, 2022.

F1 · derivative.underlying_shares: Total derivative securities include options to purchase 104,000 shares of the Issuer's common stock, held by the Reporting Person as at the transaction date, and 96,000 shares of the Issuer's preferred stock heldy by the Reporting Person, convertible to common stock at a rate of 1 share of common stock for each share of preferred stock. On February 25, 2019, the Reporting Person was granted options to purchase another 52,000 shares of the Issuer's common stock at $2.30 per share under the Issuer's 2011 Plan which will expire on February 24, 2029. Options to purchase 30% or 15,600 shares immediately vested, options to purchase another 40% or 20,800 shares will vest in two equal portions of 10,400 shares each on February 25, 2020 and 2021, respectively, and the remaining 30% or 15,600 shares will vest on February 25, 2022.

F1 · balance_after: Total derivative securities include options to purchase 104,000 shares of the Issuer's common stock, held by the Reporting Person as at the transaction date, and 96,000 shares of the Issuer's preferred stock heldy by the Reporting Person, convertible to common stock at a rate of 1 share of common stock for each share of preferred stock. On February 25, 2019, the Reporting Person was granted options to purchase another 52,000 shares of the Issuer's common stock at $2.30 per share under the Issuer's 2011 Plan which will expire on February 24, 2029. Options to purchase 30% or 15,600 shares immediately vested, options to purchase another 40% or 20,800 shares will vest in two equal portions of 10,400 shares each on February 25, 2020 and 2021, respectively, and the remaining 30% or 15,600 shares will vest on February 25, 2022.

SEC source: 0001062993-19-001974 · form4.xml · derivative · entry 1

Macdonald Sean · CIK 0001553633 · Director · CEO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,000

Underlying: Common Stock, par value $0.001 per share · 78,000 shares

Expires 2029-02-24

F1 · kind: The Reporting Person was the holder of vested and unvested options to purchase 156,000 shares of the Issuer's commons stock. On February 25, 2019, the Reporting Person was granted options to purchase another 78,000 shares of the Issuer's common stock at $2.30 per share under the Issuer's 2012 Plan which will expire on February 24, 2029. Options to purchase 30% or 23,400 shares immediately vested, options to purchase another 40% or 31,200 shares will vest in two equal portions of 15,600 each on February 25, 2020 and 2021, respectively, and the remaining 30% or 23,400 shares will vest on February 25, 2022.

F1 · shares: The Reporting Person was the holder of vested and unvested options to purchase 156,000 shares of the Issuer's commons stock. On February 25, 2019, the Reporting Person was granted options to purchase another 78,000 shares of the Issuer's common stock at $2.30 per share under the Issuer's 2012 Plan which will expire on February 24, 2029. Options to purchase 30% or 23,400 shares immediately vested, options to purchase another 40% or 31,200 shares will vest in two equal portions of 15,600 each on February 25, 2020 and 2021, respectively, and the remaining 30% or 23,400 shares will vest on February 25, 2022.

F1 · derivative.exercise_date: The Reporting Person was the holder of vested and unvested options to purchase 156,000 shares of the Issuer's commons stock. On February 25, 2019, the Reporting Person was granted options to purchase another 78,000 shares of the Issuer's common stock at $2.30 per share under the Issuer's 2012 Plan which will expire on February 24, 2029. Options to purchase 30% or 23,400 shares immediately vested, options to purchase another 40% or 31,200 shares will vest in two equal portions of 15,600 each on February 25, 2020 and 2021, respectively, and the remaining 30% or 23,400 shares will vest on February 25, 2022.

F1 · derivative.underlying_shares: The Reporting Person was the holder of vested and unvested options to purchase 156,000 shares of the Issuer's commons stock. On February 25, 2019, the Reporting Person was granted options to purchase another 78,000 shares of the Issuer's common stock at $2.30 per share under the Issuer's 2012 Plan which will expire on February 24, 2029. Options to purchase 30% or 23,400 shares immediately vested, options to purchase another 40% or 31,200 shares will vest in two equal portions of 15,600 each on February 25, 2020 and 2021, respectively, and the remaining 30% or 23,400 shares will vest on February 25, 2022.

SEC source: 0001062993-19-002015 · form4.xml · derivative · entry 5

Guzy Jeffrey J · CIK 0001415532 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock, par value $0.001 per share · 15,000 shares

Expires 2029-02-25

F4 · kind: On February 25, 2019, the Reporting Person was granted options to purchase another 15,000 shares of the Issuer's common stock at $2.30 per share under the Issuer's 2011 Plan which will expire on February 24, 2029. Options to purchase 30% or 4,500 shares immediately vested, options to purchase another 40% or 6,000 shares will vest in two equal portions of 3,000 each on February 25, 2020 and 2021, respectively, and the remaining 30% or 4,500 will vest on February 25, 2022.

F4 · shares: On February 25, 2019, the Reporting Person was granted options to purchase another 15,000 shares of the Issuer's common stock at $2.30 per share under the Issuer's 2011 Plan which will expire on February 24, 2029. Options to purchase 30% or 4,500 shares immediately vested, options to purchase another 40% or 6,000 shares will vest in two equal portions of 3,000 each on February 25, 2020 and 2021, respectively, and the remaining 30% or 4,500 will vest on February 25, 2022.

F4 · derivative.underlying_shares: On February 25, 2019, the Reporting Person was granted options to purchase another 15,000 shares of the Issuer's common stock at $2.30 per share under the Issuer's 2011 Plan which will expire on February 24, 2029. Options to purchase 30% or 4,500 shares immediately vested, options to purchase another 40% or 6,000 shares will vest in two equal portions of 3,000 each on February 25, 2020 and 2021, respectively, and the remaining 30% or 4,500 will vest on February 25, 2022.

F4 · balance_after: On February 25, 2019, the Reporting Person was granted options to purchase another 15,000 shares of the Issuer's common stock at $2.30 per share under the Issuer's 2011 Plan which will expire on February 24, 2029. Options to purchase 30% or 4,500 shares immediately vested, options to purchase another 40% or 6,000 shares will vest in two equal portions of 3,000 each on February 25, 2020 and 2021, respectively, and the remaining 30% or 4,500 will vest on February 25, 2022.

SEC source: 0001062993-19-002015 · form4.xml · derivative · entry 4

Guzy Jeffrey J · CIK 0001415532 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.001 per share · 15,000 shares

Expires 2019-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: On February 14, 2014, the Issuer's Board of Directors approved the grant to the Reporting Person, of a 5-year option to purchase 15,000 shares of the Issuer's common stock at an exercise price of $1.00 a share under the Issuer's 2011 Plan, all of which vested by February 14, 2017. On February 12, 2019, the Reporting Person exercised his options to purchase 15,000 shares of the Issuer's Common Stock.

F2 · shares: On February 14, 2014, the Issuer's Board of Directors approved the grant to the Reporting Person, of a 5-year option to purchase 15,000 shares of the Issuer's common stock at an exercise price of $1.00 a share under the Issuer's 2011 Plan, all of which vested by February 14, 2017. On February 12, 2019, the Reporting Person exercised his options to purchase 15,000 shares of the Issuer's Common Stock.

F2 · derivative.underlying_shares: On February 14, 2014, the Issuer's Board of Directors approved the grant to the Reporting Person, of a 5-year option to purchase 15,000 shares of the Issuer's common stock at an exercise price of $1.00 a share under the Issuer's 2011 Plan, all of which vested by February 14, 2017. On February 12, 2019, the Reporting Person exercised his options to purchase 15,000 shares of the Issuer's Common Stock.

F2 · balance_after: On February 14, 2014, the Issuer's Board of Directors approved the grant to the Reporting Person, of a 5-year option to purchase 15,000 shares of the Issuer's common stock at an exercise price of $1.00 a share under the Issuer's 2011 Plan, all of which vested by February 14, 2017. On February 12, 2019, the Reporting Person exercised his options to purchase 15,000 shares of the Issuer's Common Stock.

SEC source: 0001062993-19-002015 · form4.xml · nonDerivative · entry 1

Guzy Jeffrey J · CIK 0001415532 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,667

F2 · kind: On February 14, 2014, the Issuer's Board of Directors approved the grant to the Reporting Person, of a 5-year option to purchase 15,000 shares of the Issuer's common stock at an exercise price of $1.00 a share under the Issuer's 2011 Plan, all of which vested by February 14, 2017. On February 12, 2019, the Reporting Person exercised his options to purchase 15,000 shares of the Issuer's Common Stock.

F2 · shares: On February 14, 2014, the Issuer's Board of Directors approved the grant to the Reporting Person, of a 5-year option to purchase 15,000 shares of the Issuer's common stock at an exercise price of $1.00 a share under the Issuer's 2011 Plan, all of which vested by February 14, 2017. On February 12, 2019, the Reporting Person exercised his options to purchase 15,000 shares of the Issuer's Common Stock.

F2 · price: On February 14, 2014, the Issuer's Board of Directors approved the grant to the Reporting Person, of a 5-year option to purchase 15,000 shares of the Issuer's common stock at an exercise price of $1.00 a share under the Issuer's 2011 Plan, all of which vested by February 14, 2017. On February 12, 2019, the Reporting Person exercised his options to purchase 15,000 shares of the Issuer's Common Stock.

F1 · balance_after: The Reporting Person was the holder of 26,667 shares of the Issuer's common stock after giving effect to a 1-for-25 reverse split of the Issue's common stock effected on September 20, 2012.

F2 · balance_after: On February 14, 2014, the Issuer's Board of Directors approved the grant to the Reporting Person, of a 5-year option to purchase 15,000 shares of the Issuer's common stock at an exercise price of $1.00 a share under the Issuer's 2011 Plan, all of which vested by February 14, 2017. On February 12, 2019, the Reporting Person exercised his options to purchase 15,000 shares of the Issuer's Common Stock.

SEC source: 0001062993-17-004465 · form4.xml · derivative · entry 4

Macdonald Sean · CIK 0001553633 · Director · CEO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,000

Underlying: Common Stock, par value $0.001 per share · 78,000 shares

Expires 2027-08-23

F3 · shares: On August 24, 2017, the Issuer's Board of Directors approved a grant to the Reporting Person of another 10-year option to purchase 78,000 shares of the Issuer's common stock at an exercise price of $1.60 a share under the Issuer's 2011 Plan, 31,200 of the options will vest on December 31, 2017 and the remaining options to purchase 46,800 shares will vest in equal portions on December 31, 2018 and 2019, respectively.

F3 · derivative.underlying_shares: On August 24, 2017, the Issuer's Board of Directors approved a grant to the Reporting Person of another 10-year option to purchase 78,000 shares of the Issuer's common stock at an exercise price of $1.60 a share under the Issuer's 2011 Plan, 31,200 of the options will vest on December 31, 2017 and the remaining options to purchase 46,800 shares will vest in equal portions on December 31, 2018 and 2019, respectively.

F2 · balance_after: On March 29, 2016, the Issuer's Board of Directors approved a grant to the Reporting Person of a 10-year option to purchase another 78,000 shares of the Issuer's common stock at an exercise price of $2.60 a share under the Issuer's 2011 Plan, 23,400 of which immediately vested and another 23,400 of which vested on March 29, 2017. The remaining options to purchase 31,200 shares are scheduled to vest in equal parts on March 29, 2018 and 2019, respectively.

F3 · balance_after: On August 24, 2017, the Issuer's Board of Directors approved a grant to the Reporting Person of another 10-year option to purchase 78,000 shares of the Issuer's common stock at an exercise price of $1.60 a share under the Issuer's 2011 Plan, 31,200 of the options will vest on December 31, 2017 and the remaining options to purchase 46,800 shares will vest in equal portions on December 31, 2018 and 2019, respectively.

SEC source: 0001062993-17-004459 · form4.xml · derivative · entry 4

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock, par value $0.001 per share · 52,000 shares

Expires 2027-08-23

F5 · shares: On August 24, 2017, the Issuer's Board of Directors approved a grant to the Reporting Person of another 10-year option to purchase 52,000 shares of the Issuer's common stock at an exercise price of $1.60 a share under the Issuer's 2011 Plan, 20,800 of the options will vest on December 31, 2017 and the remaining options to purchase 15,600 shares and 15,600 shares will vest on December 31, 2018 and 2019, respectively.

F5 · derivative.underlying_shares: On August 24, 2017, the Issuer's Board of Directors approved a grant to the Reporting Person of another 10-year option to purchase 52,000 shares of the Issuer's common stock at an exercise price of $1.60 a share under the Issuer's 2011 Plan, 20,800 of the options will vest on December 31, 2017 and the remaining options to purchase 15,600 shares and 15,600 shares will vest on December 31, 2018 and 2019, respectively.

F4 · balance_after: Total derivative securities include options to purchase shares of the Issuer's common stock, held as at the transaction date, and 96,000 shares of the Issuer's preferred stock held by the Reporting Person, convertible to common stock at a rate of 1 share of common stock for each share of preferred stock.

SEC source: 0001062993-19-002015 · form4.xml · derivative · entry 3

Guzy Jeffrey J · CIK 0001415532 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock, par value $0.001 per share · 10,000 shares

Expires 2026-11-21

F3 · kind: On November 22, 2016, the Reporting Person was granted a 10-year option to purchase 10,000 shares of the Issuer's common stock at $2.60 per share under the Issuer's 2011 Plan, 6,000 of which vested on March 29, 2017 and the remaining 4,000 of which vested in two equal parts on March 29, 2018 and 2019, respectively.

F3 · shares: On November 22, 2016, the Reporting Person was granted a 10-year option to purchase 10,000 shares of the Issuer's common stock at $2.60 per share under the Issuer's 2011 Plan, 6,000 of which vested on March 29, 2017 and the remaining 4,000 of which vested in two equal parts on March 29, 2018 and 2019, respectively.

F3 · derivative.underlying_shares: On November 22, 2016, the Reporting Person was granted a 10-year option to purchase 10,000 shares of the Issuer's common stock at $2.60 per share under the Issuer's 2011 Plan, 6,000 of which vested on March 29, 2017 and the remaining 4,000 of which vested in two equal parts on March 29, 2018 and 2019, respectively.

F3 · balance_after: On November 22, 2016, the Reporting Person was granted a 10-year option to purchase 10,000 shares of the Issuer's common stock at $2.60 per share under the Issuer's 2011 Plan, 6,000 of which vested on March 29, 2017 and the remaining 4,000 of which vested in two equal parts on March 29, 2018 and 2019, respectively.

SEC source: 0001062993-17-004465 · form4.xml · derivative · entry 3

Macdonald Sean · CIK 0001553633 · Director · CEO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,000

Underlying: Common Stock, par value $0.001 per share · 46,800 shares

Expires 2017-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,950,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 78,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 78,000 shares at an aggregate exercise price of $78,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 31,200 of the shares in lieu of cash payment and the Reporting person received the remaining 46,800 shares.

F1 · shares: On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,950,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 78,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 78,000 shares at an aggregate exercise price of $78,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 31,200 of the shares in lieu of cash payment and the Reporting person received the remaining 46,800 shares.

F1 · derivative.underlying_shares: On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,950,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 78,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 78,000 shares at an aggregate exercise price of $78,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 31,200 of the shares in lieu of cash payment and the Reporting person received the remaining 46,800 shares.

F2 · balance_after: On March 29, 2016, the Issuer's Board of Directors approved a grant to the Reporting Person of a 10-year option to purchase another 78,000 shares of the Issuer's common stock at an exercise price of $2.60 a share under the Issuer's 2011 Plan, 23,400 of which immediately vested and another 23,400 of which vested on March 29, 2017. The remaining options to purchase 31,200 shares are scheduled to vest in equal parts on March 29, 2018 and 2019, respectively.

SEC source: 0001062993-17-004465 · form4.xml · nonDerivative · entry 1

Macdonald Sean · CIK 0001553633 · Director · CEO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,800

F1 · kind: On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,950,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 78,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 78,000 shares at an aggregate exercise price of $78,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 31,200 of the shares in lieu of cash payment and the Reporting person received the remaining 46,800 shares.

F1 · shares: On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,950,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 78,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 78,000 shares at an aggregate exercise price of $78,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 31,200 of the shares in lieu of cash payment and the Reporting person received the remaining 46,800 shares.

F1 · price: On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,950,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 78,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 78,000 shares at an aggregate exercise price of $78,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 31,200 of the shares in lieu of cash payment and the Reporting person received the remaining 46,800 shares.

SEC source: 0001062993-17-004459 · form4.xml · derivative · entry 3

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,000

Underlying: Common Stock, par value $0.001 per share · 31,200 shares

Expires 2017-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,300,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 52,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 52,000 shares at an aggregate exercise price of $52,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 20,800 of the shares and the Reporting person received the remaining 31,200 shares.

F1 · shares: On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,300,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 52,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 52,000 shares at an aggregate exercise price of $52,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 20,800 of the shares and the Reporting person received the remaining 31,200 shares.

F1 · derivative.underlying_shares: On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,300,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 52,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 52,000 shares at an aggregate exercise price of $52,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 20,800 of the shares and the Reporting person received the remaining 31,200 shares.

F4 · balance_after: Total derivative securities include options to purchase shares of the Issuer's common stock, held as at the transaction date, and 96,000 shares of the Issuer's preferred stock held by the Reporting Person, convertible to common stock at a rate of 1 share of common stock for each share of preferred stock.

SEC source: 0001062993-17-004459 · form4.xml · nonDerivative · entry 1

Leatt Christopher James · CIK 0001553632 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote 2

Disclosed balance after: 2,030,114

F1 · kind: On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,300,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 52,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 52,000 shares at an aggregate exercise price of $52,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 20,800 of the shares and the Reporting person received the remaining 31,200 shares.

F1 · shares: On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,300,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 52,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 52,000 shares at an aggregate exercise price of $52,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 20,800 of the shares and the Reporting person received the remaining 31,200 shares.

F1 · price: On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,300,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 52,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 52,000 shares at an aggregate exercise price of $52,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 20,800 of the shares and the Reporting person received the remaining 31,200 shares.

F2 · ownership.direct: Total common stock represents 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family.

F2 · ownership.nature: Total common stock represents 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family.